Thrivent Financial For Lutherans Vertex Pharmaceuticals Inc Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 91,675 shares of VRTX stock, worth $42.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
91,675
Previous 94,794 3.29%
Holding current value
$42.6 Million
Previous $44.4 Million 4.04%
% of portfolio
0.08%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$460.0 - $505.78 $1.43 Million - $1.58 Million
-3,119 Reduced 3.29%
91,675 $42.6 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $2.29 Million - $2.83 Million
5,827 Added 6.55%
94,794 $44.4 Million
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $11.3 Million - $12.3 Million
27,602 Added 44.98%
88,967 $37.2 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $4.89 Million - $5.86 Million
-14,266 Reduced 18.86%
61,365 $25 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $9.33 Million - $10 Million
-27,585 Reduced 26.73%
75,631 $26.3 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $9.45 Million - $10.6 Million
30,041 Added 41.05%
103,216 $36.3 Million
Q1 2023

May 17, 2023
SELL
$283.23 - $323.1 $6.23 Million - $7.11 Million
-22,002 Reduced 23.12%
73,175 $23.1 Million
Q4 2022

Feb 08, 2023
SELL
$285.76 - $321.48 $39,149 - $44,042
-137 Reduced 0.14%
95,177 $27.5 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $2.26 Million - $2.52 Million
-8,259 Reduced 7.97%
95,314 $27.6 Million
Q2 2022

Aug 16, 2022
SELL
$234.96 - $292.55 $305,213 - $380,022
-1,299 Reduced 1.24%
103,573 $29.2 Million
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $11.6 Million - $13.7 Million
52,466 Added 100.11%
104,872 $27.4 Million
Q4 2021

Feb 16, 2022
BUY
$177.01 - $223.45 $1.43 Million - $1.8 Million
8,056 Added 18.16%
52,406 $11.5 Million
Q3 2021

Nov 15, 2021
SELL
$181.39 - $202.99 $181 - $202
-1 Reduced -0.0%
44,350 $8.05 Million
Q2 2021

Aug 19, 2021
SELL
$187.49 - $221.1 $11,811 - $13,929
-63 Reduced 0.14%
44,351 $8.94 Million
Q1 2021

May 17, 2021
SELL
$207.02 - $241.31 $77.9 Million - $90.8 Million
-376,418 Reduced 89.45%
44,414 $9.54 Million
Q4 2020

Feb 16, 2021
BUY
$207.01 - $276.09 $4.9 Million - $6.54 Million
23,679 Added 5.96%
420,832 $99.5 Million
Q3 2020

Nov 10, 2020
SELL
$255.65 - $303.1 $9.38 Million - $11.1 Million
-36,689 Reduced 8.46%
397,153 $108 Million
Q2 2020

Aug 12, 2020
SELL
$225.48 - $295.8 $12.4 Million - $16.3 Million
-55,136 Reduced 11.28%
433,842 $126 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $4.95 Million - $6.15 Million
-24,803 Reduced 4.83%
488,978 $116 Million
Q4 2019

Feb 13, 2020
SELL
$166.71 - $223.91 $1.73 Million - $2.32 Million
-10,372 Reduced 1.98%
513,781 $112 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $6.01 Million - $6.77 Million
36,176 Added 7.41%
524,153 $88.8 Million
Q2 2019

Aug 13, 2019
SELL
$164.61 - $190.37 $15.7 Million - $18.1 Million
-95,109 Reduced 16.31%
487,977 $89.5 Million
Q1 2019

May 14, 2019
SELL
$163.73 - $194.7 $3.02 Million - $3.6 Million
-18,473 Reduced 3.07%
583,086 $107 Million
Q4 2018

Feb 15, 2019
BUY
$151.91 - $192.21 $39.1 Million - $49.5 Million
257,683 Added 74.93%
601,559 $99.7 Million
Q3 2018

Nov 15, 2018
SELL
$167.73 - $192.74 $2.33 Million - $2.67 Million
-13,870 Reduced 3.88%
343,876 $66.3 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $38.1 Million - $44.5 Million
261,618 Added 272.16%
357,746 $60.8 Million
Q1 2018

May 08, 2018
SELL
$151.6 - $177.13 $1.06 Million - $1.24 Million
-7,010 Reduced 6.8%
96,128 $15.7 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $664,984 - $753,484
4,844 Added 4.93%
103,138 $15.5 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $14.6 Million - $15.9 Million
98,294
98,294 $14.9 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email